Transgene SA (TNG)
Euronext
Closed
Oct 8, 2026
Day's Range
0.685052 wk Range
0.6850Overview - TNG - Transgene SA
Key Statistics
Valuation
Enterprise Value
98.35M
P/E (Trailing)
‪-2.80‬
P/E (Forward)
‪-3.45‬
PEG Ratio
‪-3.45‬
Price / Sales (TTM)
‪29.33‬
Price / Book
‪1.71‬
EV / EBITDA
‪-2.91‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-684.11%‬
Return on Assets
‪-24.21%‬
Return on Equity
‪-54.80%‬
Ownership
Shares Outstanding
273.88M
Float
48.86M
Held by Insiders
‪80.77%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪0.7861‬
200-Day Avg
‪0.8126‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - TNG - Transgene SA
Peers - TNG - Transgene SA
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
- TNGEuronextTransgene SA203.12MMarket Cap-57.53%52-week change-2.81P/E (Trailing)‪0.00%‬Profit Margin
- ARGXEuronextargenx SE52.87BMarket Cap+27.69%52-week change36.64P/E (Trailing)‪32.26%‬Profit Margin
- AGNEuronextAegon Ltd.11.21BMarket Cap+10.13%52-week change11.66P/E (Trailing)‪8.62%‬Profit Margin
- ABVXEuronextAbivax SA7.14BMarket Cap+13.43%52-week change-16.96P/E (Trailing)‪0.00%‬Profit Margin
- ALVIOEuronextValerio Tx Corp.279.69MMarket Cap+89.64%52-week change—P/E (Trailing)‪-190.36%‬Profit Margin
- AVTXEuronextAvantium N.V.126.03MMarket Cap-46.80%52-week change-2.94P/E (Trailing)‪-154.30%‬Profit Margin
- ALCLSEuronextCellectis S.A.125.69MMarket Cap-81.49%52-week change-1.86P/E (Trailing)‪-102.33%‬Profit Margin
Profile Summary - TNG - Transgene SA
About
Transgene SA is a French clinical-stage biotechnology company specializing in the development of virus-based immunotherapies for cancer and infectious diseases. Headquartered in Illkirch-Graffenstaden near Strasbourg and founded in 1979, it harnesses viral vector technologies to engineer treatments that stimulate the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
